Treatment of Wilson disease

Wilson disease is a very treatable condition. With proper therapy, disease progress can be halted and oftentimes symptoms can be improved. Treatment is aimed at removing excess accumulated copper and preventing its reaccumulation. Treatment for Wilson disease is a lifelong process. Patients may become progressively sicker from day to day, so immediate treatment can be critical. Treatment delays may cause irreversible damage.

Chelation therapy drugs approved for treating Wilson disease include penicillamine (Cuprimine® and Depen®) and trientine (Syprine® and Trientine Dihydrochloride) Both of these drugs act by chelation or binding of copper, causing its increased urinary excretion.

Zinc acetate is approved for treating Wilson disease under the brand names (Galzin™) in the U.S. and (Wilzin®) in Europe. Zinc acts by inducing metallothionein and blocking the absorption of copper in the intestinal tract. This action both depletes accumulated copper and prevents its reaccumulation. Zinc is used primarily for maintenance treatment and to treat asymptomatic patients and may also be used in conjunction with chelators.  Its effectiveness has been shown by more than 40 years of considerable experience in the USA and Europe. A major advantage of zinc therapy is its lack of side effects.

Patients with severe hepatitis or liver failure may require liver transplant. Patients being investigated or treated for Wilson disease should be cared for by specialists in Wilson disease or by specialists in consultation with their primary physicians. Stopping treatment completely will result in death, sometimes as quickly as within three months. Decreasing dosage of medications also can result in unnecessary disease progression.

Taking your medicine as prescribed is extremely critical to the success of Wilson disease treatment. One of the advantages of having WD is that it is VERY treatable with effective, safe medications leading to a normal life expectancy . . . IF . . . you faithfully take your medications, as prescribed, LIFELONG. There are varying reasons for non-adherence in patients with WD and your physician has probably heard them all. Adherence is especially difficult in patients who were asymptomatic as diagnosis. These patients often do not see a cause and effect relationship.

Generic Zinc Options

Gluzin™ Pharmaceutical Grade Zinc’s active ingredient is Zinc Gluconate (also called zincum gluconium) which is zinc salt that provides a good source of Zinc mineral. There are many types of zinc salt, but Zinc Gluconate is known to be more soluble than other zinc salts, and friendlier to the stomach.

Gluzin™ has been formulated with minimum fillers to help reduce allergic reactions. For more information on Gluzin™, please go to www.extremeV.com or email us at [email protected]  For information on how to receive a 15% discount for Wilson Disease Association members go to: www.gluzin.com or to order go here.

WDA Medical Advisory Committee Review

Donations

Your support allows the WDA to maintain this website, produce educational materials, support research, and hold meetings for people living with WD, their families, and the healthcare community.

Make a Donation
Make a Cryptocurrency Donation

Membership

As a member, you have the opportunity to communicate your concerns, share your experiences, learn about the most recent advances in Wilson disease treatment and research, and contribute to important decisions that need to be made so the WDA can be a strong patient advocacy group

Join Us!

WILSON DISEASE ASSOCIATION

Contact Us

More Ways to Contact Us